51.23
price up icon1.65%   0.83
after-market After Hours: 51.23
loading
Qiagen Nv stock is traded at $51.23, with a volume of 1.27M. It is up +1.65% in the last 24 hours and up +8.47% over the past month. Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
See More
Previous Close:
$50.40
Open:
$50.86
24h Volume:
1.27M
Relative Volume:
0.92
Market Cap:
$10.91B
Revenue:
$1.98B
Net Income/Loss:
$83.59M
P/E Ratio:
136.98
EPS:
0.374
Net Cash Flow:
$502.31M
1W Performance:
+6.20%
1M Performance:
+8.47%
6M Performance:
+9.15%
1Y Performance:
+18.56%
1-Day Range:
Value
$50.79
$51.58
1-Week Range:
Value
$47.66
$51.58
52-Week Range:
Value
$37.74
$51.58

Qiagen Nv Stock (QGEN) Company Profile

Name
Name
Qiagen Nv
Name
Phone
-
Name
Address
-
Name
Employee
5,700
Name
Twitter
@QIAGEN
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
QGEN's Discussions on Twitter

Compare QGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
QGEN
Qiagen Nv
51.23 10.91B 1.98B 83.59M 502.31M 0.374
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
475.03 176.18B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.81 141.70B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
549.97 43.48B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
200.82 33.02B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.35 33.01B 6.63B 1.17B 1.19B 4.05

Qiagen Nv Stock (QGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-24-25 Initiated Barclays Overweight
Apr-04-25 Downgrade Redburn Atlantic Buy → Neutral
Feb-19-25 Downgrade Robert W. Baird Outperform → Neutral
Jan-06-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-10-24 Upgrade Jefferies Hold → Buy
Oct-17-24 Downgrade HSBC Securities Buy → Hold
Jun-27-24 Upgrade Wolfe Research Peer Perform → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Dec-07-23 Upgrade Goldman Neutral → Buy
Sep-12-23 Initiated Robert W. Baird Outperform
May-23-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-18-22 Initiated Morgan Stanley Equal-Weight
Jan-18-22 Upgrade DZ Bank Hold → Buy
Oct-15-21 Resumed Cowen Market Perform
Oct-14-21 Initiated Redburn Buy
Jul-14-21 Downgrade Kepler Buy → Hold
Jun-03-21 Initiated Goldman Neutral
Oct-06-20 Resumed BofA Securities Buy
Sep-28-20 Upgrade Kepler Hold → Buy
Aug-24-20 Upgrade Citigroup Neutral → Buy
Aug-20-20 Resumed JP Morgan Overweight
Aug-17-20 Upgrade Berenberg Hold → Buy
Aug-14-20 Upgrade Deutsche Bank Hold → Buy
Aug-14-20 Upgrade Exane BNP Paribas Neutral → Outperform
Mar-04-20 Downgrade Berenberg Buy → Hold
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Neutral
Dec-26-19 Resumed BofA/Merrill Underperform
Nov-15-19 Initiated Stifel Hold
Nov-14-19 Upgrade Evercore ISI In-line → Outperform
Nov-14-19 Upgrade JP Morgan Underweight → Overweight
Nov-14-19 Upgrade Kepler Reduce → Hold
Oct-17-19 Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19 Downgrade Kepler Hold → Reduce
Oct-08-19 Downgrade Barclays Overweight → Equal Weight
Oct-08-19 Downgrade Deutsche Bank Buy → Hold
Oct-08-19 Downgrade JP Morgan Neutral → Underweight
View All

Qiagen Nv Stock (QGEN) Latest News

pulisher
10:55 AM

Qiagen N.V.'s (NYSE:QGEN) high institutional ownership speaks for itself as stock continues to impress, up 4.3% over last week - Yahoo Finance

10:55 AM
pulisher
04:33 AM

Berenberg raises Qiagen stock price target to EUR50 on growth pillars - Investing.com

04:33 AM
pulisher
Jul 23, 2025

What analysts say about Qiagen N.V. stockLightning-fast capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Qiagen N.V. stock priceHigh-velocity capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Qiagen N.V. a good long term investmentRapid wealth creation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - BioSpace

Jul 23, 2025
pulisher
Jul 22, 2025

BlackRock Discloses Significant Stake in Qiagen - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Qiagen Announces Voting Rights Notification Involving BlackRock - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider

Jul 22, 2025
pulisher
Jul 22, 2025

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

Release according to Article 40, Section 1 of the WpHG - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

Qiagen N.V. Stock Analysis and ForecastUnmatched profit growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India

Jul 22, 2025
pulisher
Jul 19, 2025

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext

Jul 19, 2025
pulisher
Jul 18, 2025

BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Maintains Target Price $53 - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo.co

Jul 18, 2025
pulisher
Jul 15, 2025

Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN

Jul 15, 2025
pulisher
Jul 11, 2025

Qiagen and Gencurix partner for oncology tests - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

QIAGEN Announces Managerial Share Transaction - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia

Jul 11, 2025
pulisher
Jul 08, 2025

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire

Jul 08, 2025
pulisher
Jul 08, 2025

QIAGEN NV : Deutsche Bank maintains a Buy rating - MarketScreener

Jul 08, 2025
pulisher
Jul 03, 2025

Baptista Research Begins Qiagen Coverage at Hold - MarketScreener

Jul 03, 2025
pulisher
Jul 03, 2025

Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN

Jul 03, 2025
pulisher
Jul 02, 2025

Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031 - MarketScreener

Jul 02, 2025
pulisher
Jul 02, 2025

Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027 - MarketScreener

Jul 02, 2025
pulisher
Jun 30, 2025

Qiagen N.V.(NYSE: QGEN) dropped from Russell 1000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Ex-Dividend Reminder: Comcast, Qiagen and HA Sustainable Infrastructure Capital - Nasdaq

Jun 30, 2025
pulisher
Jun 28, 2025

Qiagen Announces Managerial Share Transaction - TipRanks

Jun 28, 2025
pulisher
Jun 27, 2025

Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

QIAGEN Announces Election of Stephen Rusckowski as Chairman of S - GuruFocus

Jun 27, 2025

Qiagen Nv Stock (QGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research WAT
$298.47
price up icon 0.96%
diagnostics_research DGX
$171.90
price up icon 0.83%
$141.06
price up icon 2.35%
diagnostics_research LH
$267.69
price up icon 6.86%
diagnostics_research MTD
$1,260.75
price up icon 0.28%
diagnostics_research A
$120.35
price up icon 0.74%
Cap:     |  Volume (24h):